Supervisory board extends Dr. Harald Schwager's contract

• Deputy chairman of the executive board appointed until 2025
• Continuity on the executive board ensured for years
• Focus on the future development of the chemicals business with innovative products and solutions

Essen, Germany. Dr. Harald Schwager will be shaping the development of Evonik for a further three years as deputy chairman of the executive board. The supervisory board has already decided to extend his contract until 2025. It was originally due to expire next fall. Schwager (61) has a PhD in chemistry and joined Evonik from BASF in 2017. His responsibilities on Evonik's executive board include chemicals and innovation. In addition, he is responsible for the Asia growth region.

Having extended the contract with executive board chairman Christian Kullmann in June of this year, this step ensures the long-term personnel continuity of Evonik's executive board. Schwager thanked the supervisory board for its trust in him: “In the coming years, I will continue to do everything in my power to drive forward Evonik's innovative capability and position it as a best-in-class specialty chemicals company,” said Schwager. “That will include a special focus on developing sustainable solutions for customers, which we refer to as Next Generation Solutions.”